OrthopedicsJoint replacement

Total hip replacement, private package cost abroad

Compare Total hip replacement, private package prices across private international treatment corridors, including medical cost, travel, hotel stay, source quality and verification level.

No sourced private-care baseline for this origin. Official figures below are benchmarks; no savings percentage is shown.

Private-care and travel estimates are in USD. Official index figures retain their original currency and source dates.

Your options

Care Path for New York, United States. Explore public care and possible funding before comparing private providers. Your clinician and payer decide suitability and eligibility.

Information, not medical or legal advice.

US cash-pay / self-pay

Ask for a written good faith estimate if you are uninsured or will not use insurance. Medicare figures in the index are payment benchmarks, not cash prices or a complete patient bill.

Who can use it: Confirm the self-pay process with the provider and your insurer before deciding whether to use insurance.

Cost to you: varies — Confirm a written patient price or funding decision.

Reported public wait: No official figure available for this route.
  1. Request an itemised good faith estimate from each provider.
  2. Ask separately about facility, doctor, anaesthesia, tests and follow-up.
  3. Compare the complete written estimate and ask about financial assistance.

CMS self-pay estimates · Guidance reviewed: 2026-10-15

Private care near home

Ask local providers for a written quote for the complete episode of care.

Who can use it: Check clinical suitability and payment arrangements with the provider.

Cost to you: varies — Confirm a written patient price or funding decision.

Reported public wait: No official figure available for this route.
  1. Ask for a full written price and exclusions.
  2. Confirm follow-up and how complications would be handled.

Compare private options below

Published waits are historical statistics, not an appointment forecast. Costs and waits are unknown unless a source is shown. Private comparisons below are in USD; official figures retain their source currency.

What it costs and how long people wait

Public tariffs, published private prices and reported waits are shown separately, with source periods below. Covered services may differ from your package. Historical waits do not promise a current appointment.

United States · Your origin

Official public tariff

US$1,156.97 (January 2026): Medicare doctor fee benchmark, not a complete patient bill. Hospital, anaesthesia and implant are excluded.

Source: US Medicare (CMS) · Source period: January 2026 · Captured: 2026-10-14 · n=109 observations
What this figure covers

Scope: United States. Payer context: Public tariff. PFS professional fee in facility; non-QP; excludes hospital, anaesthesia and implant. Source code: 27130. The displayed figure is the median of the eligible published tariff cells.

n=109 eligible observations. n is not a patient count. Episode equivalence: unverified.

Methodology and exclusions

US$13,116.76 (October 2026): Medicare outpatient hospital payment benchmark, not a self-pay price. The separate doctor fee is excluded.

Source: US Medicare (CMS) · Source period: October 2026 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United States. Payer context: Public tariff. OPPS national unadjusted hospital outpatient facility payment; excludes separate professional fee. Source code: 27130.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Methodology and exclusions

Official wait

No official figure yet. How we collect official figures

Canada

Official public tariff

No official figure yet. How we collect official figures

Official wait

In Canada (British Columbia), the reported wait was 17 weeks — median waiting time, patients who were treated (British Columbia Ministry of Health, 2026-04-01/2026-06-30).

Source: British Columbia Ministry of Health · Source period: 2026-04-01/2026-06-30 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: Canada (British Columbia). Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Official BC surgical procedure-group percentile, all ages, scheduled inpatient/day surgeries. Wait Two begins when the health authority receives the booking form. Includes revision procedures and therefore is broader than the primary replacement basket. Consult wait excluded. No averaging of facility or authority percentiles. Definitions: https://www2.gov.bc.ca/gov/content/health/accessing-health-care/surgical-wait-times/understanding-wait-times/wait-time-procedure-groupings

Methodology and exclusions

In Canada (British Columbia), the reported wait was 51.6 weeks — 90% of patients who were treated waited this long or less (British Columbia Ministry of Health, 2026-04-01/2026-06-30).

Source: British Columbia Ministry of Health · Source period: 2026-04-01/2026-06-30 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: Canada (British Columbia). Population: patients who were treated. Reported statistic: p90. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Official BC surgical procedure-group percentile, all ages, scheduled inpatient/day surgeries. Wait Two begins when the health authority receives the booking form. Includes revision procedures and therefore is broader than the primary replacement basket. Consult wait excluded. No averaging of facility or authority percentiles. Definitions: https://www2.gov.bc.ca/gov/content/health/accessing-health-care/surgical-wait-times/understanding-wait-times/wait-time-procedure-groupings

Methodology and exclusions

Historical data (2025-04-01/2025-06-30) — not current waitIn Canada (Nova Scotia), the reported wait was 111 days — median waiting time, patients who were treated (Nova Scotia Health, 2025-04-01/2025-06-30).

Source: Nova Scotia Health · Source period: 2025-04-01/2025-06-30 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: Canada (Nova Scotia). Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Patient Access Registry Nova Scotia historical completed surgery waits in days; primary replacements and first cataract surgery. Referral-to-consultation wait is separate. Provincial quarterly aggregate, not a national estimate. Open-data dataset is a historical snapshot; newer clinical website results may differ.

Methodology and exclusions

Historical data (2025-04-01/2025-06-30) — not current waitIn Canada (Nova Scotia), the reported wait was 293 days — 90% of patients who were treated waited this long or less (Nova Scotia Health, 2025-04-01/2025-06-30).

Source: Nova Scotia Health · Source period: 2025-04-01/2025-06-30 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: Canada (Nova Scotia). Population: patients who were treated. Reported statistic: p90. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Patient Access Registry Nova Scotia historical completed surgery waits in days; primary replacements and first cataract surgery. Referral-to-consultation wait is separate. Provincial quarterly aggregate, not a national estimate. Open-data dataset is a historical snapshot; newer clinical website results may differ.

Methodology and exclusions

Chile

Official public tariff

Beneficiary tranche B: Hip replacement for patients under 65; Beneficiary tranche C: Hip replacement for patients under 65; Beneficiary tranche D: Hip replacement for patients under 65

CLP 6,630,640 (FONASA, 2026): official public payment benchmark, not a self-pay patient price; coverage and eligibility vary.

3 tariff codes at the same value

Source: FONASA · Source period: 2026 · Captured: 2026-10-14 · n=3 observations
What this figure covers

Scope: Chile. Payer context: Public tariff. Grupo 33 SAP total intervention tariff; beneficiary tranche and hip age restriction retained in evidence; inclusions unverified. Source code: 3301002.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Methodology and exclusions

What this figure covers

Scope: Chile. Payer context: Public tariff. Grupo 33 SAP total intervention tariff; beneficiary tranche and hip age restriction retained in evidence; inclusions unverified. Source code: 3302002.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Methodology and exclusions

What this figure covers

Scope: Chile. Payer context: Public tariff. Grupo 33 SAP total intervention tariff; beneficiary tranche and hip age restriction retained in evidence; inclusions unverified. Source code: 3303002.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Methodology and exclusions

Official wait

Historical data (2024) — not current waitIn Chile, the reported wait was 313 days — median waiting time, patients still on the public waiting list. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Chile. Population: patients still on the public waiting list. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Patients still on elective list at national census date; not completed-treatment duration. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. Public hospitals only. OECD source methods combine GES SIGGES and non-GES SIGTE; this is not asserted to be an exclusively non-GES cohort. National codes differ from ICD-9-CM.

Methodology and exclusions

Historical data (2024) — not current waitIn Chile, the reported wait was 292 days — median waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Chile. Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. Public hospitals only. OECD source methods combine GES SIGGES and non-GES SIGTE; this is not asserted to be an exclusively non-GES cohort. National codes differ from ICD-9-CM.

Methodology and exclusions

Historical data (2024) — not current waitIn Chile, the reported wait was 607 days — average waiting time, patients still on the public waiting list. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Chile. Population: patients still on the public waiting list. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Patients still on elective list at national census date; not completed-treatment duration. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. Public hospitals only. OECD source methods combine GES SIGGES and non-GES SIGTE; this is not asserted to be an exclusively non-GES cohort. National codes differ from ICD-9-CM.

Methodology and exclusions

Historical data (2024) — not current waitIn Chile, the reported wait was 567 days — average waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Chile. Population: patients who were treated. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. Public hospitals only. OECD source methods combine GES SIGGES and non-GES SIGTE; this is not asserted to be an exclusively non-GES cohort. National codes differ from ICD-9-CM.

Methodology and exclusions

Denmark

Official public tariff

No official figure yet. How we collect official figures

Official wait

Historical data (2024) — not current waitIn Denmark, the reported wait was 44 days — median waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure. status=D: definition differs. Measured from GP referral, not from the specialist decision (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Denmark. Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. Publicly funded patients in public/private hospitals; active waiting time only. From 2020 this is referral to treatment start, with surgery within 3 days; not strictly specialist assessment to treatment. Published definition differs from standard.

Methodology and exclusions

Historical data (2024) — not current waitIn Denmark, the reported wait was 57 days — average waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure. status=D: definition differs. Measured from GP referral, not from the specialist decision (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Denmark. Population: patients who were treated. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. Publicly funded patients in public/private hospitals; active waiting time only. From 2020 this is referral to treatment start, with surgery within 3 days; not strictly specialist assessment to treatment. Published definition differs from standard.

Methodology and exclusions

Spain

Official public tariff

No official figure yet. How we collect official figures

Official wait

Historical data (2025-12-31) — not current waitIn Spain, the reported wait was 98 days — average waiting time, patients still on the public waiting list (Spain Ministry of Health, 2025-12-31).

Source: Spain Ministry of Health · Source period: 2025-12-31 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: Spain. Population: patients still on the public waiting list. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Primary/revision status is not specified.

Methodology and exclusions

Finland

Official public tariff

No official figure yet. How we collect official figures

Official wait

Historical data (2024) — not current waitIn Finland, the reported wait was 169.2 days — average waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Finland. Population: patients who were treated. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. THL Care Register, elective inpatient/day cases with known waits; excludes negative waiting dates. Source warns reliability of waiting-list entry dates can be questioned.

Methodology and exclusions

Historical data (2024) — not current waitIn Finland, the reported wait was 142 days — median waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Finland. Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. THL Care Register, elective inpatient/day cases with known waits; excludes negative waiting dates. Source warns reliability of waiting-list entry dates can be questioned.

Methodology and exclusions

France

Official public tariff

€5,654.51 (ATIH, 2026): official public payment benchmark, not a self-pay patient price; coverage and eligibility vary.

Source: ATIH · Source period: 2026 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: France. Payer context: Public tariff. GHS public-sector base tariff from 2026 schedule; source DATE-EFFET retained separately. Source code: 08C481.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Administrative GHS baseline; group includes related procedures and may not prove all basket inclusions. Geographic/prudential adjustments, supplements and separately reimbursed devices excluded.

Methodology and exclusions

Official wait

No official figure yet. How we collect official figures

United Kingdom

Official public tariff

£7,426 (England, 2026/27): official NHS hospital tariff, not a self-pay patient price.

Source: NHS England · Source period: 2026/27 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (England). Payer context: Public tariff. Combined day case / ordinary elective spell unit price before market forces factor. Source code: HN12F.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

NHS administrative baseline; local MFF, excess bed days and applicable adjustments excluded. HRG case mix and episode inclusions require review.

Methodology and exclusions

Published private package prices

Nuffield Health Bristol Hospital

£16,120 (Nuffield Health, 2026-10-14): published package price benchmark; check the inclusions below.

Source: Nuffield Health · Source period: 2026-10-14 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (England). Payer context: Published private package. Nuffield Health Bristol Hospital.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Included in published price: Treatment only; component-level inclusions not established by this list. Excluded / priced separately: Diagnostic or investigative tests before confirmation are charged separately.

Published guide price is an approximation of treatment only. Diagnostic/investigative tests are separate. Final price varies with consultant fees, prosthesis, drugs and pre-existing conditions; a fixed all-inclusive quotation follows consultation. Package equivalence, colonoscopy sedation and cataract follow-up are not established. Not a median or a guaranteed minimum.

Methodology and exclusions

Nuffield Health Cambridge Hospital

£18,275 (Nuffield Health, 2026-10-14): published package price benchmark; check the inclusions below.

Source: Nuffield Health · Source period: 2026-10-14 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (England). Payer context: Published private package. Nuffield Health Cambridge Hospital.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Included in published price: Treatment only; component-level inclusions not established by this list. Excluded / priced separately: Diagnostic or investigative tests before confirmation are charged separately.

Published guide price is an approximation of treatment only. Diagnostic/investigative tests are separate. Final price varies with consultant fees, prosthesis, drugs and pre-existing conditions; a fixed all-inclusive quotation follows consultation. Package equivalence, colonoscopy sedation and cataract follow-up are not established. Not a median or a guaranteed minimum.

Methodology and exclusions

Ramsay New Hall Hospital

Ramsay New Hall Hospital: from £16,761 (2026-10-14). Published private package.

Source: Ramsay Health Care UK · Source period: 2026-10-14 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (England). Payer context: Published private package. Ramsay New Hall Hospital.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Published minimum guide price, not a guaranteed quotation or median. Component-level inclusions/exclusions, implant type, laterality, consultant/anaesthetist fees and follow-up are not established on this price list; cataract one-eye equivalence and diagnostic-only colonoscopy are unconfirmed. Contact hospital for a quotation. Combined colonoscopy/gastroscopy and finance repayments are excluded from extraction.

Methodology and exclusions

Official wait

In United Kingdom (England), the reported wait was Trauma and Orthopaedic Service (specialty-level wait, not a procedure-specific wait): 13.77 weeks — median waiting time, patients still on the public waiting list (NHS England (Referral to Treatment), August 2026).

Source: NHS England (Referral to Treatment) · Source period: August 2026 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (England). Population: patients still on the public waiting list. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Specialty-level proxy, not a procedure waiting time. Incomplete consultant-led referral-to-treatment pathways at month end; includes diagnostics and appointments. Published NHS median/p92 are estimates from aggregate data; values are copied, never calculated from bins. One specialty is intentionally referenced by multiple basket items; do not count these as independent cohorts.

Methodology and exclusions

In United Kingdom (England), the reported wait was Trauma and Orthopaedic Service (specialty-level wait, not a procedure-specific wait): 41.72 weeks — 92% of patients still on the public waiting list waited this long or less (NHS England (Referral to Treatment), August 2026).

Source: NHS England (Referral to Treatment) · Source period: August 2026 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (England). Population: patients still on the public waiting list. Reported statistic: p92. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Specialty-level proxy, not a procedure waiting time. Incomplete consultant-led referral-to-treatment pathways at month end; includes diagnostics and appointments. Published NHS median/p92 are estimates from aggregate data; values are copied, never calculated from bins. One specialty is intentionally referenced by multiple basket items; do not count these as independent cohorts.

Methodology and exclusions

In United Kingdom (Scotland), the reported wait was Trauma and Orthopaedic Surgery (C8); inpatient/day-case stage of treatment; completed waits (specialty-level wait, not a procedure-specific wait): 202 days — median waiting time, patients who were treated (Public Health Scotland, August 2026).

Source: Public Health Scotland · Source period: August 2026 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (Scotland). Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Published specialty-level stage-of-treatment wait, not a procedure-specific wait or full referral-to-treatment pathway. The same specialty statistic may appear for multiple basket procedures; do not count those as independent patient cohorts.

Methodology and exclusions

In United Kingdom (Scotland), the reported wait was Trauma and Orthopaedic Surgery (C8); inpatient/day-case stage of treatment; completed waits (specialty-level wait, not a procedure-specific wait): 468 days — 90% of patients who were treated waited this long or less (Public Health Scotland, August 2026).

Source: Public Health Scotland · Source period: August 2026 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (Scotland). Population: patients who were treated. Reported statistic: p90. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Published specialty-level stage-of-treatment wait, not a procedure-specific wait or full referral-to-treatment pathway. The same specialty statistic may appear for multiple basket procedures; do not count those as independent patient cohorts.

Methodology and exclusions

In United Kingdom (Scotland), the reported wait was Trauma and Orthopaedic Surgery (C8); inpatient/day-case stage of treatment; ongoing waits (specialty-level wait, not a procedure-specific wait): 159 days — median waiting time, patients still on the public waiting list (Public Health Scotland, August 2026).

Source: Public Health Scotland · Source period: August 2026 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (Scotland). Population: patients still on the public waiting list. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Published specialty-level stage-of-treatment wait, not a procedure-specific wait or full referral-to-treatment pathway. The same specialty statistic may appear for multiple basket procedures; do not count those as independent patient cohorts.

Methodology and exclusions

In United Kingdom (Scotland), the reported wait was Trauma and Orthopaedic Surgery (C8); inpatient/day-case stage of treatment; ongoing waits (specialty-level wait, not a procedure-specific wait): 375 days — 90% of patients still on the public waiting list waited this long or less (Public Health Scotland, August 2026).

Source: Public Health Scotland · Source period: August 2026 · Captured: 2026-10-14 · n=1 observations
What this figure covers

Scope: United Kingdom (Scotland). Population: patients still on the public waiting list. Reported statistic: p90. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Published specialty-level stage-of-treatment wait, not a procedure-specific wait or full referral-to-treatment pathway. The same specialty statistic may appear for multiple basket procedures; do not count those as independent patient cohorts.

Methodology and exclusions

India

Official public tariff

Package B: Cementless hip replacement

₹52,600 (2022): public PM-JAY treatment payment benchmark, not a self-pay patient price. Separately listed implants are excluded.

Published range: 46,300–55,500 INR across 3 city-tier observations

Source: PM-JAY · Source period: 2022 · Captured: 2026-10-14 · n=3 observations
What this figure covers

Scope: India. Payer context: Public tariff. HBP 2022 city-tier procedure tariff; separately mapped implants are excluded; state amendments/accreditation incentives not applied. Source code: SB038B. The displayed figure is the median of the eligible published tariff cells.

n=3 eligible observations. n is not a patient count. Episode equivalence: unverified.

Methodology and exclusions

Package A: Cemented hip replacement

₹69,900 (2022): public PM-JAY treatment payment benchmark, not a self-pay patient price. Separately listed implants are excluded.

Published range: 61,600–73,900 INR across 3 city-tier observations

Source: PM-JAY · Source period: 2022 · Captured: 2026-10-14 · n=3 observations
What this figure covers

Scope: India. Payer context: Public tariff. HBP 2022 city-tier procedure tariff; separately mapped implants are excluded; state amendments/accreditation incentives not applied. Source code: SB038A. The displayed figure is the median of the eligible published tariff cells.

n=3 eligible observations. n is not a patient count. Episode equivalence: unverified.

Methodology and exclusions

Package C: Hybrid hip replacement

₹72,300 (2022): public PM-JAY treatment payment benchmark, not a self-pay patient price. Separately listed implants are excluded.

Published range: 63,700–76,400 INR across 3 city-tier observations

Source: PM-JAY · Source period: 2022 · Captured: 2026-10-14 · n=3 observations
What this figure covers

Scope: India. Payer context: Public tariff. HBP 2022 city-tier procedure tariff; separately mapped implants are excluded; state amendments/accreditation incentives not applied. Source code: SB038C. The displayed figure is the median of the eligible published tariff cells.

n=3 eligible observations. n is not a patient count. Episode equivalence: unverified.

Methodology and exclusions

Official wait

No official figure yet. How we collect official figures

Italy

Official public tariff

No official figure yet. How we collect official figures

Official wait

Historical data (2024) — not current waitIn Italy, the reported wait was 83 days — average waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure. status=D: definition differs. status=P: provisional value (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Italy. Population: patients who were treated. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. National hospital discharge database; cataract ambulatory procedures without hospital admission are undercounted. National procedure-code deviations apply. Provisional published value. Published definition differs from standard.

Methodology and exclusions

Historical data (2024) — not current waitIn Italy, the reported wait was 44 days — median waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure. status=D: definition differs. status=P: provisional value (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Italy. Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. National hospital discharge database; cataract ambulatory procedures without hospital admission are undercounted. National procedure-code deviations apply. Provisional published value. Published definition differs from standard.

Methodology and exclusions

Norway

Official public tariff

No official figure yet. How we collect official figures

Official wait

Historical data (2023) — not current waitIn Norway, the reported wait was 192.3 days — average waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure. status=D: definition differs. Measured from GP referral, not from the specialist decision (OECD Health Statistics (Waiting Times), 2023).

Source: OECD Health Statistics (Waiting Times) · Source period: 2023 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Norway. Population: patients who were treated. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. Norwegian Patient Register. Wait starts when GP referral is received, earlier than specialist assessment; therefore OECD flags a definition difference. Latest available series here is 2023. Published definition differs from standard.

Methodology and exclusions

Historical data (2023) — not current waitIn Norway, the reported wait was 176 days — median waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure. status=D: definition differs. Measured from GP referral, not from the specialist decision (OECD Health Statistics (Waiting Times), 2023).

Source: OECD Health Statistics (Waiting Times) · Source period: 2023 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Norway. Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. Norwegian Patient Register. Wait starts when GP referral is received, earlier than specialist assessment; therefore OECD flags a definition difference. Latest available series here is 2023. Published definition differs from standard.

Methodology and exclusions

New Zealand

Official public tariff

No official figure yet. How we collect official figures

Official wait

Historical data (2024) — not current waitIn New Zealand, the reported wait was 157.6 days — average waiting time, patients still on the public waiting list. Broader procedure group; not isolated to this exact procedure. status=P: provisional value (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: New Zealand. Population: patients still on the public waiting list. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Patients still on elective list at national census date; not completed-treatment duration. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. NBRS national procedure-category selection, published estimates. 2024 provisional; yearly completed cohort and December waiting-list census. Historical revision in 2025 edition; published values copied without estimation. Provisional published value.

Methodology and exclusions

Historical data (2024) — not current waitIn New Zealand, the reported wait was 184.6 days — average waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure. status=P: provisional value (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: New Zealand. Population: patients who were treated. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. NBRS national procedure-category selection, published estimates. 2024 provisional; yearly completed cohort and December waiting-list census. Historical revision in 2025 edition; published values copied without estimation. Provisional published value.

Methodology and exclusions

Historical data (2024) — not current waitIn New Zealand, the reported wait was 154 days — median waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure. status=P: provisional value (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: New Zealand. Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. NBRS national procedure-category selection, published estimates. 2024 provisional; yearly completed cohort and December waiting-list census. Historical revision in 2025 edition; published values copied without estimation. Provisional published value.

Methodology and exclusions

Historical data (2024) — not current waitIn New Zealand, the reported wait was 126 days — median waiting time, patients still on the public waiting list. Broader procedure group; not isolated to this exact procedure. status=P: provisional value (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: New Zealand. Population: patients still on the public waiting list. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Patients still on elective list at national census date; not completed-treatment duration. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. NBRS national procedure-category selection, published estimates. 2024 provisional; yearly completed cohort and December waiting-list census. Historical revision in 2025 edition; published values copied without estimation. Provisional published value.

Methodology and exclusions

Poland

Official public tariff

No official figure yet. How we collect official figures

Official wait

In Poland, the reported wait was 229.5 days — median of reported average waiting time; 230 providers, patients who were treated (NFZ, September 2026).

Source: NFZ · Source period: September 2026 · Captured: 2026-10-14 · n=244 observations
What this figure covers

Scope: Poland. Population: patients who were treated. Reported statistic: average waiting time. Unweighted median of provider statistics; sites per provider are consolidated first. This is not a patient-level national average or median.

n=244 eligible observations; 230 providers; 1 observations excluded. n is not a patient count. Episode equivalence: unverified.

Routine NFZ benefit cohort; revisions, technique and episode inclusions are not isolated. Provider-reported mean for patients removed after treatment; excludes current waiting-list age and first available date.

Additional source pages: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13

Methodology and exclusions

Portugal

Official public tariff

No official figure yet. How we collect official figures

Official wait

Historical data (2024) — not current waitIn Portugal, the reported wait was 126 days — median waiting time, patients still on the public waiting list. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Portugal. Population: patients still on the public waiting list. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Patients still on elective list at national census date; not completed-treatment duration. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. SIGLIC hospital operational data; 2024 extract 2025-03-08; national procedure crosswalk includes ICD-9/10.

Methodology and exclusions

Historical data (2024) — not current waitIn Portugal, the reported wait was 151.4 days — median waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Portugal. Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. SIGLIC hospital operational data; 2024 extract 2025-03-08; national procedure crosswalk includes ICD-9/10.

Methodology and exclusions

Historical data (2024) — not current waitIn Portugal, the reported wait was 143.1 days — average waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Portugal. Population: patients who were treated. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. SIGLIC hospital operational data; 2024 extract 2025-03-08; national procedure crosswalk includes ICD-9/10.

Methodology and exclusions

Historical data (2024) — not current waitIn Portugal, the reported wait was 210.5 days — average waiting time, patients still on the public waiting list. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Portugal. Population: patients still on the public waiting list. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Patients still on elective list at national census date; not completed-treatment duration. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. SIGLIC hospital operational data; 2024 extract 2025-03-08; national procedure crosswalk includes ICD-9/10.

Methodology and exclusions

Sweden

Official public tariff

No official figure yet. How we collect official figures

Official wait

Historical data (2024) — not current waitIn Sweden, the reported wait was 67 days — median waiting time, patients still on the public waiting list. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Sweden. Population: patients still on the public waiting list. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Patients still on elective list at national census date; not completed-treatment duration. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. SKR/SALAR national waiting-time database. Procedure coverage varies; acute cases are generally excluded but malignancy and hip fracture are not explicitly excluded.

Methodology and exclusions

Historical data (2024) — not current waitIn Sweden, the reported wait was 80 days — median waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Sweden. Population: patients who were treated. Reported statistic: median waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. SKR/SALAR national waiting-time database. Procedure coverage varies; acute cases are generally excluded but malignancy and hip fracture are not explicitly excluded.

Methodology and exclusions

Historical data (2024) — not current waitIn Sweden, the reported wait was 104.8 days — average waiting time, patients still on the public waiting list. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Sweden. Population: patients still on the public waiting list. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Patients still on elective list at national census date; not completed-treatment duration. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. SKR/SALAR national waiting-time database. Procedure coverage varies; acute cases are generally excluded but malignancy and hip fracture are not explicitly excluded.

Methodology and exclusions

Historical data (2024) — not current waitIn Sweden, the reported wait was 104.5 days — average waiting time, patients who were treated. Broader procedure group; not isolated to this exact procedure (OECD Health Statistics (Waiting Times), 2024).

Source: OECD Health Statistics (Waiting Times) · Source period: 2024 · Captured: 2026-10-15 · n=1 observations
What this figure covers

Scope: Sweden. Population: patients who were treated. Reported statistic: average waiting time. Shown as reported by the source.

n=1 eligible observations. n is not a patient count. Episode equivalence: unverified.

Historical official OECD statistical republication; newest available year separately for each country/procedure/statistic/population, not a current appointment estimate. Completed elective treatment: specialist assessment/list entry to admission, subject to national deviations. Procedure-group proxy: hip includes partial and revision replacements, knee includes revisions, cataract has no verified one-eye restriction, and PTCA does not establish stent use. SKR/SALAR national waiting-time database. Procedure coverage varies; acute cases are generally excluded but malignancy and hip fracture are not explicitly excluded.

Methodology and exclusions

See all official figures, sources and treatment inclusions · Methodology

Current priced corridors

Plan the trip around this procedure

What to arrange if you travel for this procedure.

What changes the final quote

Compare from your city

Use the CareFare search app to enter any residence city, insurance status and treatment need in plain language.

Open treatment search
Medical disclaimer

CareFare Global compares price and logistics. It does not diagnose, recommend a treatment, or replace advice from a licensed clinician.